---
title: "System1 Director Conrad Bona Raises Stake with Share Purchase"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281052848.md"
description: "System1 Group PLC's non-executive director, Conrad Bona, has increased his stake by purchasing 11,288 shares at £2.75 each, raising his total to 40,000 shares, or 0.3% of voting rights. This transaction, disclosed under EU regulations, may indicate board confidence. The latest analyst rating for SYS1 stock is a Buy with a £327.00 price target, although concerns about high valuation and overbought signals exist. System1 specializes in marketing analytics, providing insights to enhance advertising effectiveness."
datetime: "2026-03-30T15:52:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281052848.md)
  - [en](https://longbridge.com/en/news/281052848.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281052848.md)
---

# System1 Director Conrad Bona Raises Stake with Share Purchase

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

System1 ( (GB:SYS1) ) has issued an update.

System1 Group PLC reported that non-executive director Conrad Bona has increased his stake in the company by purchasing 11,288 ordinary shares at £2.75 each on 30 March 2026. Following this transaction, Bona now holds 40,000 shares, representing about 0.3% of System1’s total voting rights, a move that marginally boosts insider ownership and may be viewed as a signal of board-level confidence in the business.

The transaction, conducted on the London Stock Exchange, was disclosed under EU Market Abuse Regulation rules governing dealings by persons discharging managerial responsibilities. System1 reiterated that further information about the group and its investor relations is available via its corporate website, with its advisers and brokers remaining the primary contacts for market participants and shareholders.

The most recent analyst rating on (GB:SYS1) stock is a Buy with a £327.00 price target. To see the full list of analyst forecasts on System1 stock, see the GB:SYS1 Stock Forecast page.

**Spark’s Take on SYS1 Stock**

According to Spark, TipRanks’ AI Analyst, SYS1 is a Outperform.

The score is driven primarily by strong financial performance (high margins, low leverage, strong ROE) and supportive recent price trend versus short-to-mid-term averages. Offsetting factors are a very expensive valuation (P/E 67.27) and overbought technical signals (RSI 78.26; Stoch 84.88), which raise near-term risk.

To see Spark’s full report on SYS1 stock, click here.

**More about System1**

System1 Group PLC is a marketing and advertising analytics company listed on London’s AIM market under the ticker SYS1. The group provides data-driven insights and tools intended to help brands and agencies test and optimize advertising effectiveness, serving clients in consumer-focused sectors seeking to improve campaign performance and returns.

**Average Trading Volume:** 53,200

**Technical Sentiment Signal:** Sell

**Current Market Cap:** £34.51M

See more insights into SYS1 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [SST.US](https://longbridge.com/en/quote/SST.US.md)
- [SSTPW.US](https://longbridge.com/en/quote/SSTPW.US.md)

## Related News & Research

- [System1 Reports Q2 Revenue Amid Ongoing Operating Losses](https://longbridge.com/en/news/295022134.md)
- [A debate is brewing over the risks and rewards of serving ads to AI agents](https://longbridge.com/en/news/294957011.md)
- [Truecaller Ads Launches 'Truecaller Pulse'; An Industry First Declared Intent Media Solution](https://longbridge.com/en/news/295164958.md)
- [Health tech’s role in obesity to expand beyond a ‘nice-to-have’](https://longbridge.com/en/news/295531247.md)
- [What is ‘Premium Content’ on Pharmaceutical Technology?](https://longbridge.com/en/news/294992448.md)